NanoString Technologies - 5 Year Stock Price History | NSTG

Historical daily share price chart and data for NanoString Technologies since 2013 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for NanoString Technologies as of November 12, 2018 is 15.27.
NanoString Technologies Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 11.7668 7.8000 18.2100 6.3400 15.2700 104.42%
2017 15.3820 22.0800 22.9900 7.2900 7.4700 -66.50%
2016 16.4954 13.6700 23.2700 11.8900 22.3000 51.60%
2015 14.0262 13.8600 19.4200 10.1900 14.7100 5.60%
2014 14.7817 16.8700 21.9900 8.2200 13.9300 -19.20%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.475B $0.115B
NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $127.843B 25.90
Medtronic (MDT) Ireland $127.434B 19.54
Stryker (SYK) United States $64.080B 24.15
Boston Scientific (BSX) United States $53.415B 26.99
Baxter (BAX) United States $33.780B 21.81
Zimmer Biomet Holdings (ZBH) United States $23.992B 15.56
Smith & Nephew SNATS (SNN) United Kingdom $16.143B 0.00
ResMed (RMD) United States $15.239B 29.06
Canopy Growth (CGC) Canada $9.087B 0.00
Perrigo (PRGO) Ireland $8.704B 13.21
Bio-Rad Laboratories (BIO) United States $8.282B 52.95
Aurora Cannabis (ACB) Canada $7.005B 66.27
Hill-Rom Holdings (HRC) United States $6.451B 20.45
Haemonetics (HAE) United States $5.768B 50.73
Insulet (PODD) United States $5.175B 0.00
ICU Medical (ICUI) United States $4.749B 26.49
Hutchison China MediTech (HCM) China $4.266B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.158B 0.00
Agios Pharmaceuticals (AGIO) United States $4.020B 0.00
Neogen (NEOG) United States $3.320B 50.28
National Vision Holdings (EYE) United States $3.309B 73.08
Aphria (APHA) $3.074B 0.00
NuVasive (NUVA) United States $2.979B 27.72
Quidel (QDEL) United States $2.599B 33.88
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.498B 21.20
AtriCure (ATRC) United States $1.262B 0.00
Cardiovascular Systems (CSII) United States $1.079B 1554.50
VAREX IMAGING (VREX) United States $1.035B 16.91
PetIQ (PETQ) United States $0.874B 28.60
Surmodics (SRDX) United States $0.855B 130.61
Meridian Bioscience (VIVO) United States $0.836B 26.65
OraSure Technologies (OSUR) United States $0.797B 44.86
Cerus (CERS) United States $0.778B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.775B 24.86
MacroGenics (MGNX) United States $0.734B 0.00
Omeros (OMER) United States $0.638B 0.00
Lantheus Holdings (LNTH) United States $0.575B 17.81
Insys Therapeutics (INSY) United States $0.568B 0.00
Owens & Minor (OMI) United States $0.567B 6.41
LeMaitre Vascular (LMAT) United States $0.527B 25.89
TG Therapeutics (TGTX) United States $0.459B 0.00
Evolus (EOLS) United States $0.416B 0.00
Quanterix (QTRX) United States $0.372B 0.00
Utah Medical Products (UTMD) United States $0.327B 21.12
Cytosorbents (CTSO) United States $0.312B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.280B 0.00
BioLife Solutions (BLFS) United States $0.258B 348.50
Surface Oncology (SURF) United States $0.227B 0.00
Rockwell Medical (RMTI) United States $0.225B 0.00
Chimerix (CMRX) United States $0.168B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.162B 0.00
Fonar (FONR) United States $0.143B 7.20
Chembio Diagnostics (CEMI) United States $0.117B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.091B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.60
Neurotrope (NTRP) United States $0.055B 0.00
CAS Medical Systems (CASM) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Capricor Therapeutics (CAPR) United States $0.030B 0.00
Valeritas Holdings (VLRX) United States $0.027B 0.00
Senestech (SNES) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00